Injectable Contraceptive Introduced in Burkina Faso

Burkina Faso’s health ministry has begun its initiative to have contraception available to 25% of married women by 2015. Depo-Provera, the injectable contraceptive, has been introduced as a “Uniject” capsule under the name, “Sayana Press.” Containing one dose of the contraceptive, the Uniject capsul...

Full description

Bibliographic Details
Main Author: Lillian Ringel
Format: Article
Language:English
Published: Columbia University Libraries 2014-07-01
Series:Voices in Bioethics
Subjects:
Online Access:https://journals.library.columbia.edu/index.php/bioethics/article/view/6550
_version_ 1811268026712981504
author Lillian Ringel
author_facet Lillian Ringel
author_sort Lillian Ringel
collection DOAJ
description Burkina Faso’s health ministry has begun its initiative to have contraception available to 25% of married women by 2015. Depo-Provera, the injectable contraceptive, has been introduced as a “Uniject” capsule under the name, “Sayana Press.” Containing one dose of the contraceptive, the Uniject capsule is a simple device that administers a long-acting drug (it has to be administered every 13 weeks). The hope is that women in Burkina Faso will eventually be able to administer the medication themselves. This is important for many reasons but mainly because, as married women, they may not want their husbands to know they are using birth control. Sayana Press has been approved as Depo-Provera in the United States since 2004.
first_indexed 2024-04-12T21:14:31Z
format Article
id doaj.art-06290ee0a351460e99811e5801f5f606
institution Directory Open Access Journal
issn 2691-4875
language English
last_indexed 2024-04-12T21:14:31Z
publishDate 2014-07-01
publisher Columbia University Libraries
record_format Article
series Voices in Bioethics
spelling doaj.art-06290ee0a351460e99811e5801f5f6062022-12-22T03:16:30ZengColumbia University LibrariesVoices in Bioethics2691-48752014-07-01110.7916/vib.v1i.6550Injectable Contraceptive Introduced in Burkina FasoLillian RingelBurkina Faso’s health ministry has begun its initiative to have contraception available to 25% of married women by 2015. Depo-Provera, the injectable contraceptive, has been introduced as a “Uniject” capsule under the name, “Sayana Press.” Containing one dose of the contraceptive, the Uniject capsule is a simple device that administers a long-acting drug (it has to be administered every 13 weeks). The hope is that women in Burkina Faso will eventually be able to administer the medication themselves. This is important for many reasons but mainly because, as married women, they may not want their husbands to know they are using birth control. Sayana Press has been approved as Depo-Provera in the United States since 2004.https://journals.library.columbia.edu/index.php/bioethics/article/view/6550ContraceptiveBurkina Faso
spellingShingle Lillian Ringel
Injectable Contraceptive Introduced in Burkina Faso
Voices in Bioethics
Contraceptive
Burkina Faso
title Injectable Contraceptive Introduced in Burkina Faso
title_full Injectable Contraceptive Introduced in Burkina Faso
title_fullStr Injectable Contraceptive Introduced in Burkina Faso
title_full_unstemmed Injectable Contraceptive Introduced in Burkina Faso
title_short Injectable Contraceptive Introduced in Burkina Faso
title_sort injectable contraceptive introduced in burkina faso
topic Contraceptive
Burkina Faso
url https://journals.library.columbia.edu/index.php/bioethics/article/view/6550
work_keys_str_mv AT lillianringel injectablecontraceptiveintroducedinburkinafaso